Navigation Links
Improve Recovery and Reproducibility with Pre-Treatment of Analytical TSK-GEL G3000SWXL Size Exclusion Columns

cular weight species during SEC analysis of the post-protein A fraction was highly variable, signaling possible adsorption of the sample to the packing materials. A pre-treatment experimental protocol with BSA was administered to reduce the variability.


Conditions of SEC analysis:
Column: TSKgel G3000SWXL, 30cm x 7.8mm, 5 micron

Elution: Phosphate Buffered Saline, pH 6.5

Sample: 50 mL injection volume, 50 mg load

Detection: 280 nm

Instrument: Waters 2690 Alliance


Results:
As can be seen in Figure 1 , recovery of the high molecular weight region, expressed as a percent of total area recovery (% HMW), of the protein A purified sample was 1.1%. Upon injecting 10 aliquots x 20 mL of 5 mg/mL bovine serum albumin (BSA) onto the column, the recovery of the %HMW species increased to 3.5%. In the absence of BSA treatment, protein A purified samples historically returned %HMW values of 1.0% to 1.4% when a column was new and gradually increased to 3.5% - 4.0% after as many as 60 injections. Interestingly, this result was only apparent with the protein A purified sample. Table 1 shows that BSA pre-treatment had no effect on the samples obtained from the downstream chromatography steps. Further characterization work indicated that elevated levels of host cell proteins (HCP) were present in the protein A purified samples with respect to the post polishing samples. The HCP were found to elute in the HMW region of the analytical SEC profile. Furthermore, when the protein A purified samp
'"/>

Source:


Page: All 1 2 3 4

Related biology technology :

1. The Best Enzyme for the Toughest PCR Challenges Improved with New Hot-Start Feature
2. Novel PCR Enhancing Factor Improves Performance of Pfu DNA Polymerase
3. Improved Sensitivity for Staining RNA with SYBR Gold Stain
4. Improve Lipid- or Calcium Phosphate-Mediated Transfection of Human Dermal Fibroblasts
5. Improved Vectors for PathDetect Trans-Reporting Systems
6. Improve Amplification Specificity with Hot Start PCR Enzyme
7. Improved Quantitative Selectivity of Clenbuterol in Human Urine using High Resolution on the TSQ Quantum Mass Spectrometer
8. Gene Expression Arrays: Highly Sensitive Detection of Expression Patterns with Improved Tools for Target Amplification
9. Improve RNA Isolation for Array Analysis and More
10. Protect RNA and Improve Target Cell Identification
11. The Worlds Best DNase Improved TURBO DNA-free

Post Your Comments:
(Date:12/1/2009)..., , INCLINE VILLAGE, Nev., Dec. 1 /PRNewswi...: PDLI ) today announced revenue guidance for the...mately $57 million, as compared with $69 million f...quarter 2008 results was the first of two installm...included in fourth quarter 2008 results was a one-...
(Date:12/1/2009)..., , NEW YORK, Dec. 1 ...arch report is available in its catalogue: ,, ...: Market dynamics and the changing healthcare and ...nker.com/p0165658/Emerging-Clinical-Trial-Location...g-healthcare-and-regulatory-environment.html ,...
(Date:12/1/2009)..., , Former Majority Leader Richard Ge...ience, Medicine, Biotech Communities for "Best an...ERSEY CITY, N.J., Dec. 1 /PRNewswire-USNewswire/ -...n biopharmaceuticals, research, medicine and techn... to discuss the importance of medical innovation i...
(Date:12/1/2009)..., , SPRINGFIELD, Ill., Dec. 1 /PRNewswi... is proud to announce that it was recently awarded...Awards event on Nov. 13 in New York City. The CLIO...and innovation in the healthcare advertising indus... the world,s most recognized awards competitions f...
Breaking Biology Technology:PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 2Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 3Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 4Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 5Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 6Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 7Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 8New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 2New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 3New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 4New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 5Prairie Heart Institute of Illinois Wins Two CLIO Healthcare Awards 2
...nited States Senate, by a vote of 63-37, has enact...an on new federal funding for embryonic stem cell ...ntial veto. , ,The measure fell short of the 67 vo...first veto of the Bush presidency. , ,The bill, kn...as enacted without the possibility of amendment, w...
...g the destruction of human embryos a line that soc... a bill that would have overturned his ban on new ...arch, and an override attempt failed in the House ...y that our decent society needs to respect, so I v...irst of his presidency. , ,The measure, known as t...
...eaker than-expected results from automotive units,...otive systems and building controls company, repor...,The annual profit outlook, however, is getting di... automotive interiors. , ,Johnson Controls, sales ... $8.4 billion from $7.1 billion for the 2005 quart...
Other Biology Technology:Senate approves bill to expand stem cell funding 2Bush vetoes stem cell research bill 2Bush vetoes stem cell research bill 3Johnson Controls reports record quarterly sales 2
(Date:12/2/2009)...reporting the first identification of substances i... changes harmless marine bacteria into killers tha...ACS, Environmental Science & Technology , a semi-...te that bleaching already has destroyed up to 30 p...are searching for ways to slow or stop the damage....
(Date:12/2/2009)...our muscles can twitch, before the thought telling...gate of sortscalled an ion channelmust open in the...e chemical signals that spur the cell to action. N...s and Technology (NIST) has allowed scientists to ...or the first time, potentially offering insights f...
(Date:12/2/2009)...m the University of Salamanca and another from Yal...tors affects the behaviour of Acanthodactylus bee...t in the Near East. According to the study, these ...rent prey if they are under pressure from predator...result, but until now there had been very few expe...
Breaking Biology News(10 mins):Nervy research: Researchers take initial look at ion channels in a model system 2Lizards change their diet to avoid predators 2Inverness Medical Innovations Inc Announces Offering of 24150 Million of Senior Notes 53667 1Inverness Medical Innovations Inc Announces Offering of 24150 Million of Senior Notes 53667 2Keryx Biopharmaceuticals Inc to Hold Conference Call on Second Quarter 2009 Financial Results on Thursday August 6 2009 at 8 3A30am EDT 13361 1Keryx Biopharmaceuticals Inc to Hold Conference Call on Second Quarter 2009 Financial Results on Thursday August 6 2009 at 8 3A30am EDT 13361 2Screening May Not Lessen Domestic Violence 53664 1Screening May Not Lessen Domestic Violence 53664 2
...lable in German . , The epidemiologists Nubia ...harles Rodolphe Brupbacher Prize for Cancer Resear...the causes of tumours such as cervical cancer thro...is studies into the health risks of smoking. The p...on has a value of 100,000 Swiss Francs for each of...
...o-Science Center, University of Copenhagen and Nat...developed a general method to study membrane prote...usand proteins, and it will reduce the way from de...ow the pharmaceutical industry is interested and p...construction. The research results are published i...
...ing the genetics of social behavior and cognitive ...nd the Salk Institute for Biological Studies have ... a rare genetic disorder known as Williams Syndrom...9, online edition of the American Journal of Medi...o visual-spatial performance while GTF2I plays a r...
Other Biology News:Brupbacher prize to Nubia Munoz and Sir Richard Peto 2Brupbacher prize to Nubia Munoz and Sir Richard Peto 3Major step for drug discovery and diagnostics 22 genes influence social behavior, visual-spatial performance in people with Williams syndrome 22 genes influence social behavior, visual-spatial performance in people with Williams syndrome 3
Mouse Anti-Calcium Channel alpha 2 delta-2 Monoclonal Antibody, Unconjugated, Clone 42 from BD Biosciences Pharmingen
Mouse Anti-Neuropilin-2 Monoclonal Antibody, Unconjugated, Clone 54 from BD Biosciences Pharmingen
Dynabeads M-450 Epoxy from Dynal Biotech
Mouse Anti-CBF-B Monoclonal Antibody, Unconjugated, Clone G-2 from Santa Cruz Biotechnology, Inc.
Biology Products: